Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | NUDT1 | P36639 | 2/20 | 0.37 |
| ▸ | MEN1 | O00255 | 2/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | G6PD | P11413 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | RAPGEF4 | Q8WZA2 | 2/20 | 0.31 |
| ▸ | HTR6 | P50406 | 1/20 | 0.30 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24594972 | 0.84 | RAPGEF4 (0.36) | NUDT1RAPGEF4 | |
| SCHEMBL16104709 | 0.79 | TSHR (0.33) | TSHRNUDT1 | |
| SCHEMBL879760 | 0.79 | TSHR (0.33) | TSHRNUDT1ALDH1A1MAPTRAPGEF4 | |
| SCHEMBL26940683 | 0.79 | CA1 (0.52) | MEN1KMT2AALDH1A1MAPTGAA | |
| SCHEMBL28169413 | 0.79 | ALDH1A1 (0.52) | TSHRNUDT1ALDH1A1GAAHTR6 | |
| SCHEMBL26739507 | 0.79 | SOS1 (0.41) | TSHRNUDT1RAPGEF4 | |
| SCHEMBL1783525 | 0.78 | TSHR (0.47) | TSHRALDH1A1MAPTHTR6 | |
| SCHEMBL1155340 | 0.76 | MEN1 (0.48) | MEN1KMT2AALDH1A1MAPTGAA | |
| SCHEMBL9876231 | 0.75 | TSHR (0.35) | TSHRNUDT1HTR6 | |
| SCHEMBL19473246 | 0.75 | POLB (0.31) | TSHRPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023142485-A1 | BORON-NITROGEN COMPOUND, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF | 季华恒烨(佛山)电子材料有限公司 | 2023-08-03 | — | — | WO | disclosed |
| EP-3395795-B1 | MALONONITRILE OXIME ETHER COMPOUND AND USE THEREOF | SHENYANG SINOCHEM AGROCHEMICALS R & D CO LTD (CN) | 2023-07-19 | — | — | EP | disclosed |
| US-20170217970-A1 | NOVEL PYRAZOLO[3,4-d]PYRIMIDINE COMPOUND OR SALT THEREOF | TAIHO PHARMACEUTICAL CO., LTD. (JP) | 2017-08-03 | — | — | US | disclosed |
| CN-103732632-B | Method for producing olefin block polymer using Group 4 transition metal complex | 住友化学株式会社 | 2017-07-07 | — | — | CN | disclosed |
| CN-103958548-B | Use the manufacture method of the olefin block polymers of multiple transition-metal catalyst | SUMITOMO CHEMICAL CO.,LTD. (JP) | 2016-05-18 | — | — | CN | disclosed |
| CN-103958548-A | Method for producing olefin block polymer using plurality of types of transition metal catalysts | SUMITOMO CHEMICAL CO | 2014-07-30 | — | — | CN | disclosed |
| CN-101878236-B | Ethylene-alpha-olefin copolymer and molded body | SUMITOMO CHEMICAL CO | 2014-05-07 | — | — | CN | disclosed |
| CN-103732632-A | Method for producing olefin block polymer using group 4 transition metal complex | SUMITOMO CHEMICAL CO | 2014-04-16 | — | — | CN | disclosed |
| CN-102336785-A | Transition metal compound and catalyst for olefin polymerization | SUMITOMO CHEMICAL CO | 2012-02-01 | — | — | CN | disclosed |
| WO-2009104785-A1 | CATALYST COMPONENT FOR POLYMERIZATION OF ETHYLENE AND PROCESS FOR PRODUCING ETHYLENE POLYMER (1) | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2009-08-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170217970-A1 | NOVEL PYRAZOLO[3,4-d]PYRIMIDINE COMPOUND OR SALT THEREOF | ERBB2, JAK2, ERBB4 | TSHR 994/4885NUDT1 1666/4885MEN1 3301/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.